logo
logo

Iisc-Incubated Mynvax Raises $4.2 Million To Develop ‘Warm’ Covid-19 Vaccine

Jul 19, 2021about 4 years ago

Amount Raised

$4.2 Million

Round Type

seed

Bengaluru

Description

Bengaluru: Mynvax, a vaccine technology startup incubated at the Society for Innovation and Development at the Indian Institute of Science, has raised $4.2 million in its Series A funding round led by venture capital firm Accel.

Company Information

Company

Mynvax

Location

Bengaluru, Karnataka, India

About

Mynvax was founded in 2017 by Varadarajan and Nadig to develop flu vaccines.